Physician profile
Sergio Lenchig
NPI 1992906002
$8,669.79
in general payments reported to CMS, 2019-2025
37 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $640 · 2021: $1,369 · 2022: $1,432 · 2023: $889 · 2024: $964 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578 · Travel and Lodging: $37.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.38 |
| Travel and Lodging | $37.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,493.93 | 2019-2025 | Intracept, Superion Indirect Decompression System |
| Medtronic USA, INC. | $1,194.18 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $1,154.61 | 2019-2025 | Xtampza |
| Interventional Pain Technologies INC. | $765.56 | 2022 | |
| Saluda Medical Americas, INC. | $647.81 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $631.06 | 2021-2024 | Intellis Adaptivestim |
| Biodelivery Sciences International, INC. | $351.76 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $271.45 | 2019-2022 | |
| Spinefrontier, INC. | $219.26 | 2024-2025 | Inspan, Facetfuse, Sijfuse |
| Stimwave Technologies Incorporated | $205.64 | 2019-2021 | |
| Zyla Life Sciences, INC. | $203.32 | 2019-2020 | |
| Curonix LLC | $175.97 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $119.32 | 2025 | Mild Device Kit |
| Daiichi Sankyo INC. | $113.23 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $95.08 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $92.10 | 2020-2021 | |
| Abbott Laboratories | $84.72 | 2019-2023 | Proclaim |
| Tersera Therapeutics LLC | $80.77 | 2019 | |
| Vertiflex, INC. | $78.80 | 2019 | |
| Spinal Simplicity, LLC | $76.75 | 2022-2024 | Ha Minuteman G3-R |
| Almatica Pharma LLC | $69.19 | 2022-2023 | Gralise |
| Pfizer INC. | $66.55 | 2019 | |
| Vertos Medical, INC. | $59.86 | 2019-2023 | Mild Device Kit |
| Amgen INC. | $58.62 | 2020-2022 | |
| Nevro Corp. | $54.70 | 2019-2021 | |
| Merit Medical Systems INC | $53.34 | 2022 | |
| Foundation Fusion Solutions, LLC | $49.32 | 2024 | |
| Nalu Medical, INC. | $30.31 | 2021 | |
| Virtus Pharmaceuticals LLC | $27.34 | 2021 | |
| Camber Spine Technologies LLC | $24.05 | 2022 | |
| Forte Bio-Pharma LLC | $22.58 | 2019 | |
| Depuy Synthes Sales INC. | $21.40 | 2019 | |
| Fidia Pharma USA INC. | $17.84 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.87 | 2021 | |
| Assertio Therapeutics, INC. | $15.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.07 | 2020 | |
| Kaleo, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Lenchig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.